Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mean First Passage Times of Higher-Dimensional Velocity Jump Processes.

Physical review letters·2026
Same author

Calcium signalling in glioblastoma networks of different topologies and possible treatments.

Mathematical biosciences·2026
Same author

Qualitative optimization of oncolytic virotherapy and immune therapy combination treatments.

Mathematical biosciences and engineering : MBE·2026
Same author

The work of Pierre Magal on differential equations, functional analysis and mathematical biology.

Journal of mathematical biology·2025
Same author

Go-or-grow models in biology: a monster on a leash.

Journal of mathematical biology·2025
Same author

50 Years Journal of Mathematical Biology.

Journal of mathematical biology·2025

Related Experiment Video

Updated: May 28, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Are more complicated tumour control probability models better?

Jiafen Gong1, Mairon M Dos Santos, Chris Finlay

  • 1Centre for Mathematical Biology, Department of Mathematical & Statistical Sciences, University of Alberta, Edmonton, AB T6G 2G1, Canada.

Mathematical Medicine and Biology : a Journal of the IMA
|October 19, 2011
PubMed
Summary

The Poissonian tumour control probability (TCP) model is recommended for routine cancer radiation treatment planning. Complex models offer similar predictions in most scenarios, but require careful parameter selection.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: May 28, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Radiation oncology
  • Mathematical modeling
  • Cancer research

Background:

  • Tumour control probability (TCP) models are crucial for predicting radiation therapy success.
  • Existing models range from simple Poissonian approaches to complex birth-death processes.
  • The choice of TCP model can impact treatment planning and outcomes.

Purpose of the Study:

  • To systematically compare six different TCP models, including Poissonian, Zaider-Minerbo, and Monte Carlo, along with their cell cycle variants.
  • To evaluate these models using realistic prostate cancer treatment protocols (fractionated radiotherapy, brachytherapy).
  • To determine the practical differences and applicability of various TCP models in clinical settings.

Main Methods:

  • Comparison of six distinct tumour control probability (TCP) models.
  • Evaluation using clinical non-uniform treatment protocols for prostate cancer.
  • Analysis of fractionated external beam radiotherapy and high/low dose rate brachytherapies.

Main Results:

  • One-compartment and two-compartment TCP models yield similar predictions in most realistic scenarios.
  • Differences emerge due to the radiosensitivity of quiescent cells in two-compartment models.
  • A unified 'effective' hazard function was developed to combine different treatment approaches.

Conclusions:

  • The Poissonian TCP model is suitable for everyday radiation treatment planning.
  • More complex models are generally not necessary unless specific conditions warrant their use.
  • Careful selection of model parameters (radiosensitivity, hazard function) is essential for accurate predictions.